| Ms Julia A Peters, MA, CCC-SLP | |
|
546 Hemlock St, Juneau, AK 99801-1435 | |
| (907) 723-6305 | |
| Not Available |
| Full Name | Ms Julia A Peters |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 546 Hemlock St, Juneau, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255490033 | NPI | - | NPPES |
| SP01701 | Medicaid | AK | |
| SP0170 | Other | AK | SLP LICENSE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP0170 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Julia A Peters, MA, CCC-SLP 546 Hemlock St, Juneau, AK 99801-1435 Ph: (907) 723-6305 | Ms Julia A Peters, MA, CCC-SLP 546 Hemlock St, Juneau, AK 99801-1435 Ph: (907) 723-6305 |
News Archive
Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sensor, developed through its partnership with Precision Sensors Instrumentation (PSI), a leading developer of security sensors.
Digoxin, a drug widely used to treat heart disease, increases the possibility of death when used by patients with a common heart rhythm problem − atrial fibrillation (AF), according to new study findings by University of Kentucky researchers. The results have been published in the prestigious European Heart Journal, and raises serious concerns about the expansive use of this long-standing heart medication in patients with AF.
The American Academy of Neurology is awarding the 2013 Michael S. Pessin Stroke Leadership Prize to Amytis Towfighi, MD, with the University of Southern California and Rancho Los Amigos National Rehabilitation Center for her research in post-stroke preventive care.
MAXIMUS announced today that it has signed a new contract with the Colorado Department of Health Care Policy and Financing to help Colorado modernize eligibility and enrollment for its Medical Assistance programs, including Medicaid and the Children's Health Insurance Program.
Resistance to the tyrosine kinase inhibitor bosutinib may be mediated by overexpression of the efflux transporter ABCB1, scientists suggest.
› Verified 2 days ago
Belinda K. Burns, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9049 Ninnis Dr, Juneau, AK 99801 Phone: 907-723-8129 Fax: 907-790-2338 | |
Hillary Dawn Landers, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 213 3rd St, Juneau, AK 99801 Phone: 907-796-7202 | |
Leah Jellison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1720 Crest St, Juneau, AK 99801 Phone: 765-994-6432 | |
Morgan Saviers, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2201 Dunn St Ste 1, Juneau, AK 99801 Phone: 907-523-8888 | |
Way With Words Speech & Language Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8217 Birch Ln, Juneau, AK 99801 Phone: 480-282-1400 | |
Robin Stratton Macdonald, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 W 11th St, Juneau, AK 99801 Phone: 907-321-7132 |